| Steve M Tung, DPM | |
|
3616 E 1st St, Los Angeles, CA 90063-2326 | |
| (323) 264-6157 | |
| Not Available |
| Full Name | Steve M Tung |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 21 Years |
| Location | 3616 E 1st St, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013060847 | NPI | - | NPPES |
| E4670 | Other | CA | CA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E4670 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| California Wound Healing Medical Group Inc. | 7315033198 | 9 |
News Archive
Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.
› Verified 4 days ago
| Provider Name | Gabriel J Halperin D P M Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619194446 PECOS PAC ID: 2163411075 Enrollment ID: O20040506001654 |
News Archive
Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.
› Verified 4 days ago
| Provider Name | California Wound Healing Medical Group Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235333972 PECOS PAC ID: 7315033198 Enrollment ID: O20071010000465 |
News Archive
Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.
› Verified 4 days ago
| Provider Name | New Hope Podiatry Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447670955 PECOS PAC ID: 5193038958 Enrollment ID: O20150722005106 |
News Archive
Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steve M Tung, DPM 3616 E. First St, Los Angeles, CA 90063 Ph: (323) 264-6157 | Steve M Tung, DPM 3616 E 1st St, Los Angeles, CA 90063-2326 Ph: (323) 264-6157 |
News Archive
Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence.
Alzheimer's disease has long been studied primarily as a disease of neurons. But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around brain cells in Alzheimer's patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.
Millennium Research Group (MRG) has conducted a detailed analysis of the US spinal implant market in its US Markets for Spinal Implants report.
› Verified 4 days ago
West Beverly Podiatry Group Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3545 Griffith Park Blvd, Los Angeles, CA 90027 Phone: 323-664-4331 Fax: 323-664-4331 | |
University Podiatry Group, Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 100 Ucla Medical Plz, #460, Los Angeles, CA 90095 Phone: 310-443-8999 Fax: 310-208-4847 | |
Western Foot & Ankle Center Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 966 S Western Ave Ste 205, Los Angeles, CA 90006 Phone: 323-733-1500 Fax: 323-733-1724 | |
Dr. Pegah Samouhi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8631 W 3rd St, Los Angeles, CA 90048 Phone: 310-657-2828 | |
Charles E Ananian, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3616 E 1st St, Los Angeles, CA 90063 Phone: 323-264-6157 Fax: 323-264-0099 | |
Saieh Khademi, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 100 Ucla Medical Plz, Suite 460, Los Angeles, CA 90024 Phone: 310-443-8999 |